GENZYME CORPORATION v. ZYDUS PHARMACEUTICALS (USA) , No. 18-2362 (Fed. Cir. 2019)

Annotate this Case

Download PDF

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ GENZYME CORPORATION, SANOFI-AVENTIS U.S., LLC, Plaintiffs-Appellees v. ZYDUS PHARMACEUTICALS (USA) INC., Defendant-Appellant ______________________ 2018-2362 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:16-cv-00540-KAJ, Circuit Judge Kent A. Jordan. ______________________ JUDGMENT ______________________ PAUL HENRY BERGHOFF, McDonnell, Boehnen, Hulbert & Berghoff, LLP, Chicago, IL, argued for plaintiffs-appellees. Also represented by ALISON JAMEEN BALDWIN, NATHANIEL PAUL CHONGSIRIWATANA, DANIEL F. GELWICKS, NICOLE E. GRIMM, JAMES LEE LOVSIN, JEREMY E. NOE, KURT WILLIAM ROHDE; JEFFREY B. BOVE, Ratner Prestia, Wilmington, DE. CHAD A. LANDMON, Axinn Veltrop Harkrider, LLP, Hartford, CT, argued for defendant-appellant. Also represented by DAVID KEELER LUDWIG, EDWARD M. MATHIAS; DAN-FENG MEI, New York, NY. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (NEWMAN, CHEN, and HUGHES, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT August 16, 2019 Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.